Sherlock Biosciences

Sherlock Biosciences aims to revolutionize molecular diagnostics through better, faster, and more affordable testing. With a unique engineering biology platform, the company is on the cusp of addressing critical challenges, ranging from rapid pathogen detection to simplified cancer diagnostics. We envision a world where our products empower users to make more effective decisions in any environment—whether in hospitals, industrial settings, developing countries, or at home. Sherlock’s team possesses deep expertise in the most impactful innovations that are transforming the field of molecular diagnostics. Our team and founders are pioneers in engineering biology, with world-class experience in CRISPR and synthetic biology. We are committed to disrupting the current healthcare model by providing diagnostic tools that allow people to easily access answers and take control of their health decisions.